Ms. Vitullo joined Domain in 1999 and became a Partner in 2004. Present board memberships include, Achillion Pharmaceuticals, Celator Pharmaceuticals, Durata Therapeutics, Esperion Therapeutics, Marinus Pharmaceuticals and VentiRx Pharmaceuticals. Past Board memberships include Calixa Therapeutics, Cerexa, Eunoe and Onyx Pharmaceuticals. In addition to investment responsibilities, she is involved in the distribution/liquidation strategies for the public companies in Domain's Venture Capital portfolios. From 2000 to 2011, Ms. Vitullo was responsible for Domain Public Equity Partners L.P., a fund focused on private investments in public companies. From 1992-1999, Ms. Vitullo was Senior Vice President at Rothschild Asset Management, Inc. where she had responsibility for the U.S. public market investments of International Biotechnology Trust plc and Biotechnology Investments Limited. From 1991-1992, Ms. Vitullo served as the Director of Corporate Communications and Investor Relations at Cephalon, a publicly traded biotechnology company. Prior to Cephalon, Ms. Vitullo spent 12 years at Eastman Kodak, most recently in Corporate Development where she was involved in the development and management of Kodak’s venture capital activities.